result
pseudotyp
lentivir
vector
express
green
fluoresc
protein
gfp
deliv
intratrach
integr
lentivir
vector
base
human
immunodefici
viru
transduc
quiescent
cell
lung
account
almost
epitheli
cell
popul
pseudotyp
lentivir
vector
envelop
glycoprotein
ebola
zair
viru
lymphocyt
choriomening
viru
lcmv
mokola
viru
vesicular
stomat
viru
vsvg
result
transduct
mous
alveolar
epithelium
gene
express
lung
balbc
mice
wane
within
day
vector
inject
intratrach
deliveri
four
pseudotyp
lentivir
vector
result
transgenespecif
tcell
activ
mous
strain
albeit
lower
achiev
intramuscular
inject
vector
perform
adopt
transfer
luciferasespecif
cell
isol
spleen
lung
donor
mice
inject
vsvgpseudotyp
lentiviru
vector
express
luciferas
muscl
lung
respect
recipi
recombinationactiv
gene
rag
defici
mice
transduc
lung
adenoviru
express
firefli
luciferas
gene
express
declin
within
day
adopt
transfer
approach
background
level
day
taken
togeth
result
suggest
loss
transduc
cell
lung
due
vsvghiv
vectormedi
activ
transgenespecif
cell
rather
result
normal
turnov
airway
cell
lentivir
vector
base
human
immunodefici
viru
effici
transduc
divid
quiescent
cell
larg
packag
capac
lentivir
vector
addit
abil
stabli
integr
host
genom
render
vector
effect
gene
transfer
tool
target
specif
cell
type
achiev
pseudotyp
lentivir
vector
surfac
glycoprotein
envelop
viral
vector
inher
tropism
specif
tissu
lentivir
vector
commonli
pseudotyp
surfac
glycoprotein
vesicular
stomat
viru
vsvg
pseudotyp
vsvg
allow
product
hightit
vector
prepar
furthermor
broad
tropism
vsvg
result
effici
transduct
variou
tissu
target
addit
vsvg
surfac
glycoprotein
envelop
virus
ebola
zair
lymphocyt
choriomening
lcmv
mokola
gibbon
ape
leukemia
respiratori
syncyti
sever
acut
respiratori
syndrom
viru
use
gener
pseudotyp
lentivir
vector
addit
lentivir
vector
nonprim
lentivir
vector
ie
felin
immunodefici
viru
also
develop
ad
advantag
improv
safeti
minim
risk
gener
wildtyp
viru
homolog
recombin
lentivir
vector
develop
lung
genet
diseas
cystic
fibrosi
accommod
larg
gene
transduc
quiescent
cell
depend
pseudotyp
target
specif
cell
popul
airway
improv
transduct
airway
epithelium
vivo
envelop
glycoprotein
deriv
virus
tropic
airway
epithelium
ebola
sever
acut
respiratori
syndrom
gener
although
transduct
effici
vitro
model
system
airway
mous
nasal
airway
epithelium
encourag
effici
transduct
lung
epithelium
pseudotyp
lentivir
vector
remain
challeng
lungdirect
gene
transfer
studi
util
vsvgpseudotyp
lentivir
vector
transduc
adult
mous
lung
fetal
mous
fetal
lamb
fetal
macaqu
lung
transduct
mous
nasal
airway
vsvgpseudotyp
lentivir
vector
requir
precondit
damag
airway
effect
transduct
lung
vsvgpseudotyp
hiv
vector
transduc
alveolar
epithelium
conduct
airway
epithelium
absenc
tightjunct
disrupt
agent
studi
evalu
transduct
effici
lentivir
vector
pseudotyp
surfac
glycoprotein
ebola
zair
viru
variant
lcmv
mokola
vsvg
lung
balbc
mice
lentivir
vector
shown
activ
tcell
respons
develop
vaccin
also
character
potenti
vector
activ
transgen
andor
vectorspecif
cell
follow
lung
deliveri
hypothes
could
compromis
potenti
approach
vivo
balbc
mous
lung
attempt
determin
whether
vector
capabl
activ
transgeneandor
vectorspecif
cell
vectortr
mice
kill
day
later
peak
transgen
express
mous
lung
data
shown
lung
fix
analysi
gfp
express
spleen
harvest
lymphocyt
isol
subsequ
analysi
gfpandor
gagspecif
tcell
respons
use
enzymelink
immunosorb
spot
elispot
assay
mice
gfp
express
evidenc
alveolar
epithelium
vector
vari
degre
effici
figur
b
vsvgand
lentivir
vector
effici
vector
follow
mokola
lcmvpseudotyp
figur
b
analysi
splenocyt
gfpand
gagspecif
cell
demonstr
signific
gfpand
gagspecif
tcell
activ
mice
treat
vsvgpseudotyp
lentiviru
vector
figur
p
analysi
varianc
studentnewmankeul
test
n
transduct
effici
lentivir
vector
balbc
mous
lung
quit
differ
compar
mous
lung
instanc
lentiviru
vector
effici
transduc
alveolar
epithelium
follow
lcmvand
mokolapseudotyp
vector
figur
f
least
effici
vector
balbc
mous
lung
vsvgpseudotyp
vector
figur
f
interest
howev
pattern
gfpspecif
tcell
activ
balbc
mous
lung
four
pseudotyp
lentivir
vector
activ
high
frequenc
gfpspecif
cell
figur
signific
activ
gagspecif
cell
observ
pseudotyp
lentivir
vector
gaug
relev
transgenespecif
cell
activ
respons
lung
deliveri
pseudotyp
lenti
viral
vector
inject
four
vector
muscl
balbc
mice
well
document
direct
muscl
inject
vector
elicit
high
frequenc
transgeneand
instanc
vectorspecif
cell
lentivir
vector
pseudotyp
lcmv
mokola
vsvg
inject
right
hindlimb
balbc
mice
unit
tu
data
shown
balbc
mice
n
necropsi
day
lentiviru
vector
inject
spleen
harvest
lymphocyt
isol
subsequ
analysi
elispot
gfpand
gag
specif
cell
balbc
mice
four
pseudotyp
lentivir
vector
activ
high
frequenc
gfpspecif
cell
figur
h
respect
also
nonstatist
signific
trend
higher
gfpspecif
tcell
activ
balbc
mice
intriguingli
observ
signific
activ
gagspecif
cell
mice
inject
vsvgpseudotyp
lentiviru
vector
figur
vsvgpseudotyp
lentiviru
vector
deliveri
mous
lung
activ
transgenespecif
cell
figur
g
next
evalu
impact
transgenespecif
cell
longterm
gene
express
mediat
deliveri
vsvgpseudotyp
lentiviru
vector
mous
lung
vector
inject
balbc
mous
lung
gene
transfer
effici
well
transgenespecif
tcell
activ
monitor
longitudin
day
singl
vector
dose
instil
specif
vectortr
mice
kill
day
peak
transgen
express
propos
turnov
time
airway
epithelium
term
gfp
express
vsvgpseudotyp
lenti
viru
vectormedi
gene
express
alveolar
epithelium
higher
balbc
mous
lung
day
p
student
ttest
figur
respect
although
gene
express
stabl
mous
lung
day
signific
decreas
p
analysi
varianc
studentnewmankeul
test
number
gfpexpress
cell
day
interestingli
gfpspecif
cell
present
earli
day
increas
day
still
present
day
vector
inject
figur
balbc
mice
number
gfpposit
alveolar
epitheli
cell
low
remain
stabl
day
figur
day
howev
signific
decreas
number
gfpexpress
cell
end
experi
day
rare
gfpexpress
cell
observ
figur
compar
mice
observ
similar
gfpspecif
tcell
activ
day
howev
unlik
mice
balbc
mice
gfpspecif
tcell
respons
peak
day
remain
high
level
day
end
experi
figur
taken
togeth
gfp
express
transgenespecif
tcell
activ
data
suggest
gfpspecif
cell
destroy
gfpexpress
cell
balbc
mous
lung
around
week
vector
inject
evidenc
signific
elev
gfpspecif
cell
signific
decreas
gfpexpress
cell
inde
balbc
mice
found
clear
correl
high
frequenc
gfpspecif
cell
figur
diminut
gfp
express
lung
figur
directli
assess
whether
transgeneandor
vectorspecif
cell
activ
respons
lentiviru
vector
deliveri
lung
assess
longterm
gene
express
mice
recombinationactiv
gene
rag
defici
mice
devoid
major
convent
popul
b
cell
cell
vsvgpseudotyp
lentiviru
vector
inject
mous
lung
gfp
express
monitor
day
peak
gene
express
day
propos
turnov
time
airway
epithelium
mous
model
vector
transduc
alveolar
epithelium
day
differ
gfp
express
observ
ragdefici
mice
figur
howev
day
gfp
express
airway
epithelium
mice
significantli
reduc
p
student
ttest
compar
gfp
express
airway
epithelium
mice
remain
similar
level
observ
day
figur
deciph
whether
activ
transgenespecif
cell
could
destroy
transgeneexpress
cell
mous
lung
perform
seri
adopt
transfer
studi
studi
use
luciferas
transgen
use
allow
longitudin
assess
transgen
express
use
luminesc
donor
mice
consist
group
mice
inject
lung
muscl
either
vsvgpseudotyp
lentiviru
vector
express
luciferas
luc
vsvghivegfpluc
vector
express
firefli
luciferas
figur
peak
transgenespecif
tcell
activ
conting
upon
vector
rout
instil
group
donor
mice
inject
variou
time
point
adopt
transfer
allow
transfer
cell
peak
tcell
activ
group
day
group
mice
inject
im
vsvg
hivegfpluc
vector
vsvghivegfpluc
vector
also
includ
group
mice
receiv
inject
exclud
vectorspecif
kill
recipi
mice
receiv
lung
day
group
mice
inject
im
vector
recipi
donor
splenocyt
mice
inject
intranas
vector
day
time
adopt
transfer
day
lymphocyt
isol
donor
mice
lunglymphocyt
mice
administ
vector
splenocyt
mice
administ
vector
im
intraven
inject
recipi
mice
ratio
specif
mice
inject
intraven
naiv
lunglymphocyt
ii
naiv
splenocyt
iii
activ
lunglymphocyt
iv
group
mice
receiv
naiv
lunglymphocyt
naiv
splenocyt
mice
diminut
express
follow
adopt
transfer
figur
interestingli
group
mice
receiv
naiv
lunglymphocyt
ii
vsvghivegfpluc
activ
lunglymphocyt
iii
activ
lunglymphocyt
unexplain
transient
nonsignific
increas
gene
express
day
subsid
day
figur
mous
group
inject
intraven
either
lunglymphocyt
splenocyt
isol
mice
inject
vsvgpseudotyp
lentiviru
vector
vector
express
wane
significantli
p
student
ttest
within
day
respect
day
near
detect
sensit
xenogen
imag
system
calip
life
scienc
hopkinton
figur
effect
achiev
lymphocyt
mice
immun
vector
administ
either
lungderiv
lymphocyt
im
splenocyt
impress
diminut
express
warrant
evalu
lung
tissu
recipi
ragdefici
mice
day
end
experi
sign
inflamm
observ
evid
inflamm
lung
section
treat
mice
figur
compar
control
group
consist
mice
inject
naiv
lunglymphocyt
naiv
splenocyt
figur
e
respect
lentivir
vector
develop
effici
deliveri
larg
therapeut
gene
diseas
airway
epithelium
interestingli
airwaydirect
lentivir
vector
gene
transfer
studi
perform
mous
nasal
airway
tissu
model
key
featur
human
conduct
airway
tightjunct
format
airway
cell
composit
combin
small
surfac
area
eas
deliveri
allow
assess
gene
transfer
effici
preferenti
tropism
studi
deliv
lentivir
vector
directli
lung
airway
vivo
sinn
et
al
demonstr
lentivir
vector
base
felin
immunodefici
viru
express
firefli
luciferas
effect
transduc
balbc
mous
nasal
airway
epithelium
result
yearlong
transgen
express
howev
anoth
studi
kremer
et
al
show
lentiviru
vectormedi
gene
transfer
mous
nose
low
wane
within
month
vector
inocul
propos
turnov
mous
airway
epithelium
order
month
ref
diminut
laczexpress
cell
kremer
studi
could
explain
normal
turnov
posit
transduc
termin
differenti
airway
cell
light
howev
recent
report
mous
airway
epithelium
turnov
order
month
ref
plausibl
explan
loss
gene
express
time
kremer
studi
activ
cytolyt
cell
hypothes
lentiviru
vectormedi
transduct
resid
lung
antigenpres
cell
could
activ
transgeneandor
vectorspecif
cell
could
neg
impact
effect
gene
transfer
mous
lung
epithelium
four
differ
pseudotyp
lentivir
vector
inject
balbc
mice
observ
high
level
transgenespecif
cell
frequenc
similar
observ
follow
im
inject
vector
mice
one
four
vector
vsvgpseudotyp
lentiviru
vector
activ
transgeneand
vectorspecif
cell
follow
deliveri
differ
tcell
activ
balbc
mice
appear
depend
vector
perform
lung
lcmv
mokolapseudotyp
vector
transduc
alveolar
epithelium
mous
model
equal
well
interestingli
longitudin
gene
express
studi
kinet
gfpspecif
tcell
activ
two
mous
model
differ
peak
gfpspecif
tcell
activ
mice
found
around
day
wherea
balbc
mice
appear
around
day
correl
frequenc
gfpspecif
tcell
activ
correspond
number
gfpexpress
cell
airway
vectortr
anim
observ
pattern
diminut
gfp
express
soon
peak
gfpspecif
tcell
activ
vsvgpseudotyp
lentiviru
vector
equal
effici
activ
gfpspecif
cell
mous
strain
given
avail
mice
studi
cytolyt
properti
lunglymphocyt
also
splenocyt
activ
respons
lung
muscl
deliveri
either
vsvgpseudotyp
lentiviru
vector
adenoviru
vector
confirm
previou
find
adopt
transfer
adenovirusactiv
splenocyt
mice
destroy
transgeneexpress
cell
also
found
lymphocyt
isol
lung
mice
inject
adenoviru
destroy
transgeneexpress
cell
importantli
demonstr
vsvgpseudotyp
lentivir
vector
also
potenti
elicit
cytolyt
transgenespecif
cell
deliv
lung
mice
becom
increasingli
appar
therapeut
benefit
viralmedi
gene
therapi
may
hinder
activ
destruct
cell
activ
respons
therapeut
gene
product
andor
gene
transfer
vector
inde
long
known
adenoviru
vector
deliveri
lung
activ
cytolyt
transgenespecif
cell
hamper
develop
adenoviru
gene
therapi
vector
find
suggest
similar
issu
associ
applic
pseudotyp
lentivir
vector
lung
may
hinder
develop
vector
gene
therapi
pulmonari
genet
diseas
cystic
fibrosi
studi
use
gfp
luciferas
report
gene
studi
transgenespecif
tcell
activ
follow
lentivirusmedi
gene
transfer
mous
lung
transgen
demonstr
elicit
transgenespecif
cell
balbc
mice
nonimmunogen
transgen
includ
rhesu
rhesu
chorion
gonadotropin
express
self
antigen
demonstr
lack
transgenespecif
immun
respons
activ
largeanim
gene
transfer
studi
howev
gene
therapi
genet
diseas
caus
specif
gene
mutat
highli
probabl
express
normal
therapeut
gene
product
recogn
host
nonself
antigen
thu
activ
transgenespecif
cell
potenti
advers
effect
inde
use
comput
analysi
predict
likelihood
cftr
cystic
fibrosi
transmembran
conduct
regul
specif
tcell
activ
follow
express
therapeut
cftr
gene
cystic
fibrosi
subject
common
mutat
delet
phenylalanin
residu
ref
propos
express
therapeut
cftr
cystic
fibrosi
subject
cftr
mutat
could
subject
antigen
crosspresent
activ
quiescent
cftrspecif
cell
develop
lentivir
vector
gene
therapi
pulmonari
diseas
propos
evalu
impact
transgenespecif
cell
lentiviralbas
preclin
anim
studi
vsvg
encod
respect
lcmv
mokola
vsvg
viral
envelop
use
gener
pseudotyp
lentiviru
vector
previous
describ
pseudotyp
lentiviru
vector
produc
tripl
transfect
cell
use
capo
precipit
method
vector
resuspend
complet
dulbecco
modifi
eagl
medium
store
tuml
determin
vector
stock
count
gfpposit
cell
limit
dilut
cell
prepar
lentiviru
vector
underw
qualiti
control
presenc
replicationcompet
lentiviru
monitor
antigen
express
use
elisa
allianc
elisa
perkinelm
waltham
previous
shown
lentiviru
vector
stock
titer
rang
tuml
use
replicationdefici
vector
express
either
lacz
averag
titer
particlesml
creat
previous
describ
experi
involv
product
vivo
evalu
pseudotyp
lentivir
adeno
viral
vector
perform
biosafeti
level
contain
approv
institut
biosafeti
committe
univers
pennsylvania
experi
balbc
mice
purchas
jackson
laboratori
bar
harbor
main
use
week
age
mice
hous
specif
pathogenfre
condit
univers
pennsylvania
translat
research
laboratori
anim
procedur
protocol
approv
institut
anim
care
use
committe
univers
pennsylvania
muscl
inject
group
mice
anaesthet
ketaminexylazin
inject
im
right
hindlimb
tu
two
site
pseudotyp
lentiviru
vector
mice
kill
day
spleen
harvest
lung
inject
trachea
expos
midlin
incis
tu
viru
final
volum
phosphatebuff
salin
pb
instil
trachea
gaug
needl
upon
complet
instil
needl
remov
pressur
gentli
appli
tracheal
punctur
site
skin
fascia
close
one
layer
interrupt
sutur
vicryl
vector
tu
also
deliv
intranas
previous
describ
necropsi
lung
fixinfl
neutral
buffer
formalin
room
temperatur
rt
dark
hour
lung
wash
twice
pb
frozen
optim
cut
temperatur
compound
cryosect
prepar
mount
vectashield
contain
transduct
effici
estim
examin
highpow
field
cryosect
interv
intraven
inject
solut
inject
via
tail
vein
experi
perform
quadrupl
least
two
separ
occas
adopt
transfer
splenocyt
lunglymphocyt
mice
inject
im
either
vsvgpseudotyp
lentiviru
vector
express
luciferas
luc
adenoviru
vector
serotyp
express
firefli
luciferas
lacz
mice
kill
peak
transgenespecif
tcell
activ
either
spleen
lung
day
vsvgpseudotyp
lentiviru
vector
deliv
im
vector
deliv
day
vector
deliv
im
splenocyt
lunglymphocyt
harvest
dose
contain
either
splenocyt
lungderiv
lymphocyt
inject
intraven
via
tail
vein
one
donor
mous
one
recipi
mous
recipi
ragdefici
mice
background
j
jackson
laboratori
inject
intranas
vector
express
day
express
recipi
mice
monitor
day
day
adopt
transfer
splenocyt
spleen
harvest
treat
mice
transfer
cellgro
mediatech
herndon
va
rt
tissu
homogen
filter
cell
strainer
cell
centrifug
minut
rpm
cell
pellet
resuspend
fresh
media
centrifug
minut
rpm
cell
pellet
resuspend
complet
media
dulbecco
modifi
eagl
medium
heatinactiv
fetal
bovin
serum
penicillinstreptomycin
mmoll
hepe
mmoll
nonessenti
amino
acid
cell
overlaid
onto
ficollpaqu
gradient
layer
centrifug
minut
rpm
result
highli
pure
popul
spleenderiv
lymphocyt
harvest
interfac
wash
pb
centrifug
minut
rpm
splenocyt
resuspend
complet
media
lunglymphocyt
lung
inflat
trachea
ml
solut
uml
collagenas
worthington
biochem
lakewood
nj
uml
sigmaaldrich
st
loui
mo
rpmi
invitrogen
carlsbad
ca
trachea
remov
lung
incub
shaker
hour
tissu
remnant
homogen
filter
bd
bioscienc
franklin
lake
nj
cell
suspens
collect
centrifug
minut
rpm
cell
pellet
resuspend
fresh
media
centrifug
minut
rpm
pellet
resuspend
percol
solut
ge
healthcar
piscataway
nj
underlay
percol
solut
creat
gradient
gradient
centrifug
minut
rpm
result
cell
interphas
contain
purifi
lunglymphocyt
care
collect
new
steril
tube
cell
wash
twice
pb
follow
centrifug
minut
rpm
cell
resuspend
complet
media
elispot
assay
assay
perform
use
elispot
mous
set
bd
pharmingen
san
diego
ca
accord
manufactur
instruct
briefli
elispot
plate
precoat
ml
antimous
captur
antibodi
overnight
well
block
complet
cultur
medium
minimum
hour
rt
splenocyt
ad
well
densiti
cellswel
stimul
gfp
gag
specif
peptid
librari
luciferas
gfqsmytfv
epitop
cell
incub
co
hour
posit
control
phorbol
myrist
acet
ionomycin
ref
use
neg
control
cell
incub
absenc
peptid
follow
overnight
incub
well
vigor
wash
water
follow
subsequ
incub
biotinyl
antimous
detect
antibodi
hour
rt
follow
three
wash
well
incub
streptavidinhorseradish
peroxidas
antibodi
hour
rt
well
wash
follow
pb
develop
use
substrat
set
bd
pharmingen
color
develop
monitor
stop
minut
later
wash
well
distil
water
dri
overnight
rt
spot
count
use
elispot
reader
imag
mice
inject
intraperitoneali
mgml
dluciferin
calip
life
scienc
ie
luciferin
per
g
bodi
weight
five
minut
later
mice
anaesthet
ketaminexylazin
imag
within
minut
anesthesia
use
ivisr
xenogen
imag
system
quantit
signal
photon
per
second
calcul
use
live
imag
softwar
calip
life
scienc
statist
analysi
data
present
perform
use
sigmastat
program
spss
chicago
il
statist
signific
set
p
statist
power
result
present
mean
sd
student
ttest
use
twogroup
comparison
analysi
varianc
studentnewmankeul
test
multiplegroup
comparison
